| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5208829
Max Phase: Preclinical
Molecular Formula: C30H35N5O
Molecular Weight: 481.64
Associated Items:
Representations
Canonical SMILES: Cc1ccc(Cc2c(C)nc3c(C(=O)N4CCN(c5cccc(C(C)C)c5)CC4)cnn3c2C)cc1
Standard InChI: InChI=1S/C30H35N5O/c1-20(2)25-7-6-8-26(18-25)33-13-15-34(16-14-33)30(36)28-19-31-35-23(5)27(22(4)32-29(28)35)17-24-11-9-21(3)10-12-24/h6-12,18-20H,13-17H2,1-5H3
Standard InChI Key: LLDZSSAQGIPVNI-UHFFFAOYSA-N
Associated Targets(Human)
RuvB-like 1 59 Activities
RuvB-like 2 47 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 481.64 | Molecular Weight (Monoisotopic): 481.2842 | AlogP: 5.33 | #Rotatable Bonds: 5 |
| Polar Surface Area: 53.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 3.51 | CX LogP: 5.87 | CX LogD: 5.87 |
| Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.39 | Np Likeness Score: -1.72 |
References
| 1. Zhang G, Wang F, Li S, Cheng KW, Zhu Y, Huo R, Abdukirim E, Kang G, Chou TF.. (2022) Discovery of small-molecule inhibitors of RUVBL1/2 ATPase., 62 [PMID:35364523] [10.1016/j.bmc.2022.116726] |
Source
Source(1):